Home
#Global Trends
#Local Dynamics
#M&A
#Regulations
#Knowledge

Category: Uncategorized

China approves new targeted therapy for advanced gastric cancer

23/01/2026 Published by vivi

Expansion of treatment indications in China On January 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Enhertu (trastuzumab... Read more

Tags: #Global Trends

Corxel Pharmaceuticals secures $287m to advance cardiometabolic pipeline

23/01/2026 Published by vivi

Major financial milestone via Series D1 funding On January 23, 2026, Corxel Pharmaceuticals announced the closure of a $287 million... Read more

Category: Uncategorized

Tags: #Global Trends

Update on Infectious Disease Trends in Ho Chi Minh City (Early 2026)

23/01/2026 Published by vivi

Positive downward trend in infection rates As of the third week of 2026, Ho Chi Minh City has reported a... Read more

Category: Uncategorized

Tags: #Local Dynamics

United States officially concludes withdrawal from WHO

23/01/2026 Published by vivi

Termination of relations and resource withdrawal On January 23, the U.S. Department of Health and Human Services (HHS) announced the... Read more

Category: Uncategorized

Tags: #Global Trends

Expansion of free vaccines in the National Expanded Program on Immunization

23/01/2026 Published by vivi

Nationwide rollout of Rota vaccine As of January 2026, Vietnam has officially implemented the nationwide distribution of free Rotavirus vaccines... Read more

Category: Uncategorized

Tags: #Local Dynamics

Kuva Labs Acquires Lisata Therapeutics to Expand Cancer Diagnostic and Therapeutic Pipeline

22/01/2026 Published by vivi

Kuva Labs, a specialist in cancer imaging, has entered into a binding agreement to acquire Lisata Therapeutics, a biotech firm... Read more

Category: Uncategorized

Tags: #M&A

FDA Outlines Draft Policy on Using MRD to Expedite Multiple Myeloma Drug Approvals

22/01/2026 Published by vivi

The U.S. Food and Drug Administration (FDA) has issued a draft guidance for the industry, proposing the use of Minimal... Read more

Category: Uncategorized

Tags: #Global Trends

EU Approves Otsuka’s Dawnzera as First RNA-Targeted Therapy for HAE

22/01/2026 Published by vivi

The European Commission (EC) has granted marketing authorization for Otsuka’s Dawnzera (donidalorsen) for the routine prevention of recurrent attacks in... Read more

Category: Uncategorized

Tags: #Global Trends